VOLITIONRX LIMITED

Analyst Reco. VolitionRx Limited

Equities

VNRX

US9286611077

Market Closed - Nyse Other stock markets 01:30:00 01/06/2024 am IST			5-day change	1st Jan Change
0.7057 ^USD	+3.60%		-3.01%	-1.58%

14/05	Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024
13/05	VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Cantor Fitzgerald Adjusts Price Target on VolitionRX to $2.50 From $2.10, Maintains Overweight Rating	16/11	MT
Cantor Fitzgerald Adjusts Price Target on VolitionRX to $2.10 From $3, Keeps Overweight Rating	16/23/16	MT
Inflation, Rate-Hike Concerns Push US Equity Futures Lower	17/23/17	MT
Benchmark Capital Downgrades VolitionRX to Hold From Buy	01/23/01	MT
EF Hutton Initiates VolitionRX at Buy With $6 Price Target	19/22/19	MT
Maxim Group Adjusts Price Target on VolitionRX to $5 From $8, Reiterates Buy Rating	23/22/23	MT
Aegis Capital Adjusts Price Target on VolitionRX to $6 From $9, Reiterates Buy Rating	15/22/15	MT
VOLITIONRX : Cantor Fitzgerald Initiates VolitionRX at Overweight With $8 Price Target	10/21/10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer